GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » EV-to-Revenue

Getinge AB (Getinge AB) EV-to-Revenue : 1.68 (As of Jun. 18, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Getinge AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Getinge AB's enterprise value is $5,109 Mil. Getinge AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $3,040 Mil. Therefore, Getinge AB's EV-to-Revenue for today is 1.68.

The historical rank and industry rank for Getinge AB's EV-to-Revenue or its related term are showing as below:

GNGBF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.15   Med: 1.98   Max: 4.15
Current: 1.7

During the past 13 years, the highest EV-to-Revenue of Getinge AB was 4.15. The lowest was 1.15. And the median was 1.98.

GNGBF's EV-to-Revenue is ranked better than
70.02% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.085 vs GNGBF: 1.70

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-18), Getinge AB's stock price is $21.17. Getinge AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $11.16. Therefore, Getinge AB's PS Ratio for today is 1.90.


Getinge AB EV-to-Revenue Historical Data

The historical data trend for Getinge AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB EV-to-Revenue Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 1.91 4.00 2.10 2.10

Getinge AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 1.82 1.78 2.10 1.98

Competitive Comparison of Getinge AB's EV-to-Revenue

For the Medical Devices subindustry, Getinge AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Getinge AB's EV-to-Revenue falls into.



Getinge AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Getinge AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5108.881/3039.657
=1.68

Getinge AB's current Enterprise Value is $5,109 Mil.
Getinge AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,040 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getinge AB  (OTCPK:GNGBF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Getinge AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=21.17/11.16
=1.90

Getinge AB's share price for today is $21.17.
Getinge AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getinge AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Getinge AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB (Getinge AB) Business Description

Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.